Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Lijecnicki Vjesnik
|
August 27, 2014
[The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies--a single center experience]
Zdravko Mitrović, Igor Komljenović, Ozren Jaksic, et al.
Acta Haematologica
|
May 19, 2016
The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis
Marko Lucijanic, Vlatko Pejsa, Ozren Jaksic, et al.
International Journal of Hematology
|
October 13, 2017
Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis
Marko Lucijanic, Zdravko Mitrovic, David Cicic, et al.
Leukemia & Lymphoma
|
December 18, 2019
Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia
Vlatko Pejsa, Marko Lucijanic, Anamarija Vrkljan Vuk, et al.
European Journal of Haematology
|
March 21, 2023
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem)
Zdravko Mitrovic, Dino Dujmovic, Ozren Jaksic, et al.
Hematology (Amsterdam, Netherlands)
|
September 15, 2017
High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis
Marko Lucijanic, Ana Livun, Tajana Stoos-Veic, et al.
Wiener Klinische Wochenschrift
|
January 27, 2018
Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis
Marko Lucijanic, Ivo Veletic, Dario Rahelic, et al.
Hemasphere
|
November 21, 2022
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases
Davor Galusic, Sandra Basic-Kinda, Andela Pijuk, et al.
Blood Cancer Journal
|
April 21, 2022
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
Keith W Pratz, Panayiotis Panayiotidis, Christian Recher, et al.
The New England Journal of Medicine
|
August 14, 2020
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Courtney D DiNardo, Brian A Jonas, Vinod Pullarkat, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Lijecnicki Vjesnik
|
August 27, 2014
[The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies--a single center experience]
Zdravko Mitrović, Igor Komljenović, Ozren Jaksic, et al.
Acta Haematologica
|
May 19, 2016
The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis
Marko Lucijanic, Vlatko Pejsa, Ozren Jaksic, et al.
International Journal of Hematology
|
October 13, 2017
Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis
Marko Lucijanic, Zdravko Mitrovic, David Cicic, et al.
Leukemia & Lymphoma
|
December 18, 2019
Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia
Vlatko Pejsa, Marko Lucijanic, Anamarija Vrkljan Vuk, et al.
European Journal of Haematology
|
March 21, 2023
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem)
Zdravko Mitrovic, Dino Dujmovic, Ozren Jaksic, et al.
Hematology (Amsterdam, Netherlands)
|
September 15, 2017
High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis
Marko Lucijanic, Ana Livun, Tajana Stoos-Veic, et al.
Wiener Klinische Wochenschrift
|
January 27, 2018
Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis
Marko Lucijanic, Ivo Veletic, Dario Rahelic, et al.
Hemasphere
|
November 21, 2022
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases
Davor Galusic, Sandra Basic-Kinda, Andela Pijuk, et al.
Blood Cancer Journal
|
April 21, 2022
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
Keith W Pratz, Panayiotis Panayiotidis, Christian Recher, et al.
The New England Journal of Medicine
|
August 14, 2020
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Courtney D DiNardo, Brian A Jonas, Vinod Pullarkat, et al.
Page
of 4